Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium Bromide Inhalation Solution in COPD
NCT04780984Phase 2Completed
- Sponsor
- Nephron Pharmaceuticals Corporation
- Start
- Nov 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Nephron Pharmaceuticals Corporation. Started Nov 2020; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04780984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04780984.